{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "PLN", "esgPopulated": false, "market": "pl_market", "longName": "Pharmena S.A.", "marketState": "REGULAR", "regularMarketPrice": 6.74, "messageBoardId": "finmb_30339356", "exchange": "WSE", "shortName": "PHARMENA", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Warsaw", "regularMarketChangePercent": 0.0, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 1.7999997, "fiftyTwoWeekLowChangePercent": 0.3643724, "fiftyTwoWeekRange": "4.94 - 7.0", "fiftyTwoWeekHighChange": -0.26000023, "fiftyTwoWeekHighChangePercent": -0.03714289, "fiftyTwoWeekLow": 4.94, "fiftyTwoWeekHigh": 7.0, "earningsTimestamp": 1680087540, "earningsTimestampStart": 1680087540, "earningsTimestampEnd": 1680087540, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.14, "firstTradeDateMilliseconds": 1266825600000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1684134479, "regularMarketDayHigh": 6.74, "regularMarketDayRange": "6.74 - 6.74", "regularMarketDayLow": 6.74, "regularMarketVolume": 12, "regularMarketPreviousClose": 6.74, "bid": 6.46, "ask": 6.74, "fullExchangeName": "Warsaw", "financialCurrency": "PLN", "regularMarketOpen": 6.74, "averageDailyVolume3Month": 1150, "averageDailyVolume10Day": 1239, "sharesOutstanding": 11137800, "bookValue": -0.532, "fiftyDayAverage": 6.3624, "fiftyDayAverageChange": 0.37759972, "fiftyDayAverageChangePercent": 0.059348628, "twoHundredDayAverage": 5.96815, "twoHundredDayAverageChange": 0.77184963, "twoHundredDayAverageChangePercent": 0.12932812, "marketCap": 75068768, "priceToBook": -12.669172, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "symbol": "PHR.WA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "ul. W\u00f3lczanska 178", "city": "L\u00f3dz", "zip": "90-530", "country": "Poland", "phone": "48 422 91 33 70", "fax": "48 422 91 33 71", "website": "https://www.pharmena.eu", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in L\u00f3dz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.", "fullTimeEmployees": 24, "companyOfficers": [{"maxAge": 1, "name": "Mr. Konrad  Palka", "title": "Pres of Management Board, CEO & Pres", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marzena  Wieczorkowska", "title": "VP of the Management Board and VP of R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}